Literature DB >> 10658633

Expression and action of cyclic GMP-dependent protein kinase Ialpha in inflammatory hyperalgesia in rat spinal cord.

Y X Tao1, A Hassan, E Haddad, R A Johns.   

Abstract

Several lines of evidence have shown a role for the nitric oxide/cyclic guanosine monophosphate signaling pathway in the development of spinal hyperalgesia. However, the roles of effectors for cyclic guanosine monophosphate are not fully understood in the processing of pain in the spinal cord. The present study showed that cyclic guanosine monophosphate-dependent protein kinase Ialpha but not Ibeta was localized in the neuronal bodies and processes, and was distributed primarily in the superficial laminae of the spinal cord. Intrathecal administration of a selective inhibitor of cyclic guanosine monophosphate-dependent protein kinase Ialpha, Rp-8-[(4-chlorophenyl)thio]-cGMPS triethylamine, produced a significant antinociception demonstrated by the decrease in the number of flinches and shakes in the formalin test. This was accompanied by a marked reduction in formalin-induced c-fos expression in the spinal dorsal horn. Moreover, cyclic guanosine monophosphate-dependent protein kinase Ialpha protein expression was dramatically increased in the lumbar spinal cord 96 h after injection of formalin into a hindpaw, which occurred mainly in the superficial laminae on the ipsilateral side of a formalin-injected hindpaw. This up-regulation of cyclic guanosine monophosphate-dependent protein kinase Ialpha expression was completely blocked not only by a neuronal nitric oxide synthase inhibitor, 7-nitroindazole, and a soluble guanylate cyclase inhibitor, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, but also by an N-methyl-D-aspartate receptor antagonist, dizocilpine maleate (MK-801). The present results indicate that noxious stimulation not only initially activates but also later up-regulates cyclic guanosine monophosphate-dependent protein kinase Ialpha expression in the superficial laminae via an N-methyl-D-aspartate-nitric oxide-cyclic guanosine monophosphate signaling pathway, suggesting that cyclic guanosine monophosphate-dependent protein kinase Ialpha may play an important role in the central mechanism of formalin-induced inflammatory hyperalgesia in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10658633     DOI: 10.1016/s0306-4522(99)00438-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  16 in total

1.  Involvement of NO-cGMP pathway in anti-hyperalgesic effect of PDE5 inhibitor tadalafil in experimental hyperalgesia.

Authors:  K V Otari; C D Upasani
Journal:  Inflammopharmacology       Date:  2015-07-10       Impact factor: 4.473

2.  Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil.

Authors:  Chandrashekhar S Patil; Vijay Pal Singh; Shrinivas K Kulkarni
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

3.  Effect of inhibition of spinal cord glutamate transporters on inflammatory pain induced by formalin and complete Freund's adjuvant.

Authors:  Myron Yaster; Xiaowei Guan; Ronald S Petralia; Jeffery D Rothstein; Wei Lu; Yuan-Xiang Tao
Journal:  Anesthesiology       Date:  2011-02       Impact factor: 7.892

4.  Reduced inflammatory hyperalgesia with preservation of acute thermal nociception in mice lacking cGMP-dependent protein kinase I.

Authors:  Irmgard Tegeder; Domenico Del Turco; Achim Schmidtko; Matthias Sausbier; Robert Feil; Franz Hofmann; Thomas Deller; Peter Ruth; Gerd Geisslinger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

5.  cGMP produced by NO-sensitive guanylyl cyclase essentially contributes to inflammatory and neuropathic pain by using targets different from cGMP-dependent protein kinase I.

Authors:  Achim Schmidtko; Wei Gao; Peter König; Sandra Heine; Roberto Motterlini; Peter Ruth; Jens Schlossmann; Doris Koesling; Ellen Niederberger; Irmgard Tegeder; Andreas Friebe; Gerd Geisslinger
Journal:  J Neurosci       Date:  2008-08-20       Impact factor: 6.167

6.  Protein kinase B/Akt is required for complete Freund's adjuvant-induced upregulation of Nav1.7 and Nav1.8 in primary sensory neurons.

Authors:  Lingli Liang; Longchang Fan; Bo Tao; Myron Yaster; Yuan-Xiang Tao
Journal:  J Pain       Date:  2013-04-30       Impact factor: 5.820

7.  Formalin injection causes a coordinated spinal cord CO/NO-cGMP signaling system response.

Authors:  Xiaoyou Shi; Xiangqi Li; J David Clark
Journal:  Mol Pain       Date:  2005-11-18       Impact factor: 3.395

8.  Pain modulation by nitric oxide in the spinal cord.

Authors:  Marco Aurélio M Freire; Joanilson S Guimarães; Walace Gomes Leal; Antonio Pereira
Journal:  Front Neurosci       Date:  2009-09-15       Impact factor: 4.677

9.  Additive antinociception between intrathecal sildenafil and morphine in the rat formalin test.

Authors:  Myung Ha Yoon; Kyung Deok Park; Hyung Gon Lee; Woong Mo Kim; Tae Hoon An; Yeo Ok Kim; Lan Ji Huang; Cui Jin Hua
Journal:  J Korean Med Sci       Date:  2008-12-24       Impact factor: 2.153

10.  Protein phosphatase 2A regulates central sensitization in the spinal cord of rats following intradermal injection of capsaicin.

Authors:  Xuan Zhang; Jing Wu; Yongzhong Lei; Li Fang; William D Willis
Journal:  Mol Pain       Date:  2006-03-20       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.